| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/14/2009 | US20090123910 Method of efficient extraction of protein from cells |
| 05/14/2009 | US20090123638 Monosaccharide production system |
| 05/14/2009 | US20090123529 Nucleic acid immunological composition for human metapneumovirus |
| 05/14/2009 | US20090123497 Chromatographic method and system for purifying a botulinum toxin |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123476 Targeted binding agents directed to upar and uses thereof |
| 05/14/2009 | US20090123475 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens |
| 05/14/2009 | US20090123466 Anti-cd40 monoclonal antibody |
| 05/14/2009 | US20090123463 Methods and compositions for inducing apoptosis |
| 05/14/2009 | US20090123461 Human podocalyxin alternative-spliced forms and uses thereof |
| 05/14/2009 | US20090123450 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/14/2009 | DE60226243T2 Peptid-bildendes Enzymgen, Pepid-bildendes Enzym und Dipeptidherstellungsverfahren Peptide-forming enzyme gene PEPID-forming enzyme and Dipeptidherstellungsverfahren |
| 05/14/2009 | DE102008045214A1 Conversion of highly charged nitrogen containing water into protein- and fat containing biomass, comprises converting energy depleted water with high nitrogen concentration into protein containing biomass by aerobic assimilation |
| 05/14/2009 | CA2743032A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 05/14/2009 | CA2706700A1 Compositions and methods for generating antibodies |
| 05/14/2009 | CA2704556A1 West nile virus vaccine, and method for production thereof |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058327A2 Genes encoding insect odorant receptors and uses thereof |
| 05/13/2009 | EP2058006A1 Anti-CCR5 antibody |
| 05/13/2009 | EP2058004A1 Mannose immunogens for HIV-1 |
| 05/13/2009 | EP2057274A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 05/13/2009 | EP2057265A2 Compositions for reducing cell adhesion to bubbles |
| 05/13/2009 | EP2057185A1 Polymyxin derivatives and uses thereof |
| 05/13/2009 | EP2056853A1 Combination therapy |
| 05/13/2009 | EP1824875A4 Plant proteins having an abscisic acid binding site and methods of use |
| 05/13/2009 | EP1605058B1 Method of screening light chain of antibody light chains |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | CN101432423A Method for extracting components from a yeast cell culture |
| 05/13/2009 | CN101432422A Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101432301A Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 05/13/2009 | CN101432293A Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 05/13/2009 | CN101432018A IL-13 binding agents |
| 05/13/2009 | CN101432015A Functional antibodies |
| 05/13/2009 | CN101429537A Method for high-density fermentation production of reductive glutathione with saccharomyces cerevisiae |
| 05/13/2009 | CN101429252A Anti-bladder cancer target superantigen and preparation method thereof |
| 05/13/2009 | CN100487118C Production process of recombinant human horny cell growth factor-2 |
| 05/13/2009 | CN100487114C Crystal harvest from fermentation broth |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/12/2009 | US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 05/12/2009 | US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 05/12/2009 | US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531631 Selected from calcium, magnesium, nickel, cobalt, iron or zinc ion and an acetyltriptophan or sodium caprylate stabilizer, to selectively agglutinate impurities; low speed centrifugation or ultrafiltration; genetically engineered albumin; side effect reduction |
| 05/12/2009 | US7531630 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531626 Tenebrio antifreeze proteins |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531523 Recombinant nucleic acid encoding a human sodium channel NaV1.3 polypeptide; diagnostic kit for detecting a nucleic acid that encodes the polypeptide |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531356 exposing host cells in vitro that comprising genetic vector consisting a polynucleotide and a heterologous reporter gene operably linked to the polynucleotide, to test agents, then measuring and comparing the reporter gene expression level to that of a control cell that is not exposed to the test agent |
| 05/12/2009 | US7531351 Liquid-gas-phase exposure reactor for cell culturing |
| 05/12/2009 | US7531348 Recombinant yeast for lignocellulose raw materials |
| 05/12/2009 | US7531340 Peptide-forming enzyme gene |
| 05/12/2009 | US7531336 Methods for producing recombinant histidine-tagged inosine nonophosphate dehydrogenase polypeptides |
| 05/12/2009 | US7531335 Modified cytochrome p450 monooxygenases |
| 05/12/2009 | US7531332 esterifying L-PHE to generate a lower alkyl ester of L-phenylalanine, condensing the lower alkyl ester of L-phenylalanine with N-acyl-L-aspartic anhydride to obtain a lower alkyl ester of N-acyl- alpha -L-aspartyl-L-phenylalanine, separating, hydrogenating to form lower alkyl ester of alpha ASP-PHE |
| 05/12/2009 | US7531331 Butynol I esterase |
| 05/12/2009 | US7531330 Heat resistant lyase for use in producing optically active cyanohydrins; drug design |
| 05/12/2009 | US7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/12/2009 | US7531325 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531323 Diabetes-mediating proteins and therapeutic uses thereof |
| 05/12/2009 | US7531322 Using tissue specific gene transfer element as tool in somatic gene therapy |
| 05/12/2009 | US7531321 Fibroblast growth factor-like molecules and uses thereof |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | US7531317 Fluorescence polarization assay to detect protease cleavage |
| 05/12/2009 | US7531177 Surface protein of leptospira |
| 05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
| 05/12/2009 | CA2400143C Recombinant conglutinin and producing method thereof |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2157864C Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/12/2009 | CA2109977C Giardia vaccines |
| 05/09/2009 | CA2610098A1 Production of recombinant human hemoglobin using pichia yeast |
| 05/07/2009 | WO2009058956A1 Signal sequences and co-expressed chaperones for improving protein production in a host cell |
| 05/07/2009 | WO2009058446A1 Recombinant factor viii having increased stability |
| 05/07/2009 | WO2009057664A1 Antibody and use thereof |
| 05/07/2009 | WO2009057622A1 Method for production of human growth hormone improved in efficiency |
| 05/07/2009 | WO2009056803A1 Methods and compositions |
| 05/07/2009 | WO2009023562A3 Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| 05/07/2009 | WO2007100357A3 Stem cell factor-like protein scfa1 and uses thereof |
| 05/07/2009 | WO2007061936A3 Clearance of abnormal iga1 in iga1 deposition diseases |
| 05/07/2009 | WO2007051063A3 Gpcr expressing cell lines and antibodies |
| 05/07/2009 | WO2007014162A3 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 05/07/2009 | WO2006132809A3 Monoclonal antibody reagents |
| 05/07/2009 | WO2006125202A3 Anti- mcp-1 antibodies, compositions, methods and uses |
| 05/07/2009 | WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
| 05/07/2009 | WO2006017813A3 Methods and compositions for detecting steroids |
| 05/07/2009 | US20090119805 Nuleic acid constructs and methods for producing altered seed oil compositions |
| 05/07/2009 | US20090119797 Gro-1 herbicide resistance gene and methods for its use |
| 05/07/2009 | US20090118483 Light-driven energy generation using proteorhodopsin |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118185 Recombinant factor viii having reduced inactivation by activated protein c |